| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152167 Biodegradable block polymers for drug delivery, and methods related thereto |
| 06/23/2011 | US20110152155 Subtilase variants |
| 06/23/2011 | US20110152107 Drug Screening Via Nanpore Silicon Filters |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151566 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto |
| 06/23/2011 | US20110151565 Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method |
| 06/23/2011 | US20110151564 Method for proliferation of cells on polyelectrolyte multilayer films and use thereof, particularly for the preparation of cellular biomaterials |
| 06/23/2011 | US20110151563 Collagen Materials, Films and Methods of Making Same |
| 06/23/2011 | US20110151562 White blood cell differentiation reagent and method |
| 06/23/2011 | US20110151561 Differentiation of human embryonic stem cells |
| 06/23/2011 | US20110151560 Differentiation of human embryonic stem cells |
| 06/23/2011 | US20110151559 Compounds for Modulating TRPV3 Function |
| 06/23/2011 | US20110151558 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/23/2011 | US20110151557 Compositions and methods for transfection of rna and controlled stabilization of transfected rna |
| 06/23/2011 | US20110151556 Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue |
| 06/23/2011 | US20110151555 Compositions and methods for growing human embryonic cells |
| 06/23/2011 | US20110151554 Method for culturing and subculturing primate embryonic stem cell, as well as method for inducing differentiation thereof |
| 06/23/2011 | US20110151543 Cell separation method using hydrophobic solid supports |
| 06/23/2011 | US20110151535 Separation of cultured cells |
| 06/23/2011 | US20110151522 Glucoamylase Variants |
| 06/23/2011 | US20110151521 cDNA SYNTHESIS IMPROVEMENTS |
| 06/23/2011 | US20110151518 Method for modifying chromosomes |
| 06/23/2011 | US20110151515 Production of fc-fusion polypeptides in eukaryotic algae |
| 06/23/2011 | US20110151513 Shrna-mediated inhibition of expression of alpha-1,6-fucosyltransferase |
| 06/23/2011 | US20110151512 Oligopeptide-free cell culture media |
| 06/23/2011 | US20110151506 Process for Culturing Adherent Cells |
| 06/23/2011 | US20110151484 hERG MUTANTS AND USES THEREOF |
| 06/23/2011 | US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1 |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151473 Polynucleotides and Polypeptides Encoding Receptors |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151447 Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151092 Gluten quality wheat varieties and methods of use |
| 06/23/2011 | US20110151091 Gluten quality wheat varieties and methods of use |
| 06/23/2011 | US20110151036 Aromatase activator |
| 06/23/2011 | US20110151013 Amphiphilic block copolymers for nucleic acid delivery |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/23/2011 | US20110151005 Methods and means for soft tissue engineering |
| 06/23/2011 | US20110150941 Epithelial delivery |
| 06/23/2011 | US20110150936 Anti-tumoral cells |
| 06/23/2011 | US20110150934 Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer |
| 06/23/2011 | US20110150928 Unique avian reoviridae |
| 06/23/2011 | US20110150925 Cell-based systems for producing influenza vaccines |
| 06/23/2011 | US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 06/23/2011 | US20110150913 Torque teno virus (ttv) isolates and compositions |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150903 Fgf-r4 receptor-specific antagonists |
| 06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
| 06/23/2011 | US20110150896 Antibody against PCRV |
| 06/23/2011 | US20110150895 Antibody specifically binding to angiopoietin-2 and use thereof |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150887 Methods and products relating to gsk3beta regulation |
| 06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150876 Prognosis and Treatment of Breast Cancer |
| 06/23/2011 | US20110150874 Fusion proteins, uses thereof and processes for producing same |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150856 Compositions and methods for treatment of vitiligo |
| 06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/23/2011 | US20110150848 Cell Suspension Preparation Technique and Device |
| 06/23/2011 | US20110150847 Method of three-dimensionally culturing chondrocytes |
| 06/23/2011 | US20110150845 Methods and compositions for modulating immunological tolerance |
| 06/23/2011 | US20110150844 Compositions and methods for controlling proliferation and differentiation of cells |
| 06/23/2011 | US20110150842 Derivation of Embryonic Stem Cells |
| 06/23/2011 | US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 06/23/2011 | US20110150823 Cell Tissue Gel Containing Collagen and Hyaluronan |
| 06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 06/23/2011 | US20110150768 Compositions and methods for delivering inhibitory oligonucleotides |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
| 06/23/2011 | US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof |
| 06/23/2011 | US20110150758 Tracking of bone marrow cells for metastasis screening |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784787A1 Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue |
| 06/23/2011 | CA2784696A1 Method for optimising a biopharmaceutical production process |
| 06/23/2011 | CA2784596A1 Beta-cell replication promoting compounds and methods of their use |
| 06/23/2011 | CA2784100A1 A continuous culturing device |
| 06/23/2011 | CA2783000A1 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
| 06/23/2011 | CA2782977A1 Tmem22 peptides and vaccines including the same |
| 06/23/2011 | CA2782815A1 Decellularized adipose tissue |
| 06/22/2011 | EP2336775A2 High affinity TCR proteins and methods |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336337A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 06/22/2011 | EP2336336A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| 06/22/2011 | EP2336334A1 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |